The role of osteoanabolic agents in the management of patients with osteoporosisleolai65Aug 2, 20221 min readMcClung MR, Rothman MS , Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL.Postgrad Med. 2022 Aug;134(6):541-551. doi: 10.1080/00325481.2022.2069582. Epub 2022 May 30.PMID: 35635798 Review.
Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care ...Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators...
To Break or Not to Break (Again): Is That the Question?Kherani RB, Singh S. CRAJ. 2022;32(3):1 2 * Posted with permission from publisher
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative ReviewKendler DL, Cosman F, Stad RK, Ferrari S . Adv Ther. 2022 Jan;39(1):58-74. doi: 10.1007/s12325-021-01936-y. Epub 2021 Nov 11. PMID:...